Vote Scores
Filings read through

How funds voted at Ascendis Pharma A/S

Ticker
ASND
SEC company number
1612042
Filers reporting
58, year to 30 June 2026
Latest meeting on file
Meetings on file
3

In the year to 30 June 2026, 58 filers on Form N-PX reported votes at Ascendis Pharma A/S. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 244 marks to the ballot items, each with or against management. 97.5% of the marks are with management.

On say-on-pay, 1 of the 1 reporting filers that marked the item voted against management. This is 100.0% of the filers. Of the reported shares, 100.0% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

By filers reporting in the year to 30 June 2026, Ascendis Pharma A/S was number 4,828 of 11,972 companies with a page and votes in that year. The number of filers reporting at Ascendis Pharma A/S fell by 63.5% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category CAPITAL STRUCTURE is 22.6% of the vote records at Ascendis Pharma A/S. At all companies on this site, it is 6.9%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 23 Mar 2026

58 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    7 nominees. 97.1% of the reported votes are for. 7 filers withheld from or voted against at least one nominee.

    712 vote records from 57 filers. 2 of the 57 filers that marked the item voted against management.

    • Positions of 16 fund families
    • For 16
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    2 vote records from 2 filers. 1 of the 1 filer that marked the item voted against management. 1 filer gave no management mark.

  3. Item 3: Audit-related items (auditor ratification)

    100 vote records from 57 filers. 2 of the 57 filers that marked the item voted against management.

    • Positions of 16 fund families
    • For 16
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    144 vote records from 54 filers. 0 of the 54 filers that marked the item voted against management.

    • Positions of 16 fund families
    • For 16
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    218 vote records from 53 filers. 1 of the 53 filers that marked the item voted against management.

    • Positions of 16 fund families
    • For 15
    • Split or no vote 1
  6. Item 6: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    34 vote records from 22 filers. 0 of the 22 filers that marked the item voted against management.

    • Positions of 4 fund families
    • For 4

Positions of the fund families at the meeting of 23 Mar 2026

No single ballot item here has the position of a fund family. Director elections and grouped items are not in this table.

Every meeting on file

Meetings of Ascendis Pharma A/S, from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026586100.0%
year to 30 June 202515970.0%
year to 30 June 2024153850.0%

Say-on-pay, season by season

Say-on-pay at Ascendis Pharma A/S: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202658100.0%100.0%
year to 30 June 20251590.0%0.0%
year to 30 June 202415350.0%95.3%
Ascendis Pharma A/S and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management100.0%6.6%
Reported shares against management100.0%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Ascendis Pharma A/S by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS2,75638.0%
SECTION 14A SAY-ON-PAY VOTES60.1%
AUDIT-RELATED6278.7%
SHAREHOLDER RIGHTS AND DEFENSES300.4%
CAPITAL STRUCTURE1,63722.6%
COMPENSATION4816.6%
CORPORATE GOVERNANCE1,57021.7%
OTHER1391.9%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Ascendis Pharma A/S. https://votescores.com/company/ascendis-pharma-a-s/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Ascendis Pharma A/S are on file?
3 meetings are on file, from 30 May 2024 to 23 Mar 2026. 3 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Ascendis Pharma A/S?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Ascendis Pharma A/S reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Ascendis Pharma A/S, grouped by company. The name is the most common spelling among filers. The ticker and the SEC company number come from the SEC company tickers file, matched on the exact name. The filers wrote the filings. Filings read through .